UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000005732
Receipt number	R000006695
Scientific Title	Assessment of clinical efficacy and safety in capecitabine plus intermittent oxaliplatin (intermittent CapeOx)together with Bevacizumab as the first-line therapy for patients with advanced colorectal cancer; multicenter phase II trial
Date of disclosure of the study information	2011/06/07
Last modified on	2011/06/07 10:33:54

---